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A B S T R A C T
The pathogenesis of hepatic ischemia/reperfusion (I/R) is mediated through the genera-
tion of oxidative and nitrosative stress-induced cell injury. Hence, the present study was
designed to evaluate the hepatoprotective effect of quercetin (QR) compared to N-acetylcysteine
(NAC) against hepatic I/R injury in rats and to assess iNOS, eNOS and NOSTRIN protein ex-
pressions, as a possible mechanism of its hepatoprotective effect. Hepatic ischemia was
surgically performed by occlusion of hepatic pedicle (hepatic artery, portal vein, bile duct)
that supplies the left and medial lobes (approximately 70% of the total liver mass), for 30
min with a vascular clamp followed by releasing the clamp and the liver was reperfused
for 30 min. QR-pretreatment increased eNOS protein expression with simultaneous de-
crease in iNOS and NOSTRIN protein expressions. It also decreased serum aspartate
aminotransferase (AST), alanine aminotransferases (ALT) and hepatic myeloperoxidase (MPO)
activities. In addition, it restored the depleted content of reduced glutathione (GSH) and de-
creased malondialdehyde (MDA) and nitric oxide (NO) levels. A notable finding is that QR
alleviated I/R-induced histopathological changes.Therefore, the present study illustrates the
hepatoprotective effect of quercetin compared to N-acetylcysteine against ischemia/
reperfusion-induced liver injury by inhibiting oxidative stress and by modulating iNOS, eNOS
and NOSTRIN protein expressions.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beni-Suef Uni-
versity. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Ischemia/reperfusion (I/R) is a phenomenon whereby deliv-
ery of oxygen upon reperfusion to an organ after a period of
hypoxia leads to accentuated cellular injury. In 1975, this form
of injury in the liver was recognized, during experimental liver
transplantation studies, as a clinically important pathologi-
cal disorder (Teoh and Farrell, 2003). Also, I/R is a common
problem encountered in a variety of clinical conditions such
as hepatic trauma, sepsis (Yildiz et al., 2008), hepatic tumors
resection and hepatic pedicle clamping (Pringle maneuver)
during a liver surgery (van Gulik et al., 2007). I/R injury could
be severe enough leading to significant morbidity and mor-
tality (Siriussawakul et al., 2010). During reperfusion, excessive
reactive oxygen species (ROS) generation (Jaeschke, 2003),
Kupffer cells activation, interstitial edema, neutrophils infil-
tration and release of inflammatory cytokines were reported
(Montalvo-Jave et al., 2008). In addition, various mediators such
as nitric oxide (NO) are involved in the ischemic injury. NO
plays a paradoxical role in liver physiology where a
cytoprotective effect can result from small amounts of NO
induced by endothelial nitric oxide synthase (eNOS) isoform
while overproduction of NO induced by inducible nitric oxide
synthase (iNOS) isoform may be lethal to hepatic tissues (Lin
et al., 2004). Its byproduct, peroxynitrite (ONOO−) also causes
further hepatic injury due to its potent oxidative effect (Jaeschke,
2003). Zimmermann et al. (2002) stated that eNOS is translo-
cated by eNOS traffic inducer (NOSTRIN) from the plasma
membrane to vesicle-like subcellular structures leading to
strongly attenuated eNOS-dependent NO production. There
is an imbalance between pro-oxidants which significantly in-
crease and the endogenous antioxidant levels which
significantly decrease during reperfusion (Montalvo-Jave et al.,
2008). Therefore, the administration of exogenous antioxi-
dants can significantly decrease the severity of I/R injury.
Quercetin (QR) is one of the most abundant natural flavonol
type flavonoids (Kuo et al., 1998; Pawlikowska-Pawle˛ga et al.,
2003) in food and beverage sources that are part of the human
diet such as apples, onions, broccoli, lettuce, tea, coffee, and
tomatoes (Yousef et al., 2010). It is the most potent antioxi-
dant of the flavonoid family and possesses strong anti-
inflammatory properties (Manach et al., 2005; Yousef et al.,
2010). It was also reported that QR has protective effects against
I/R-induced renal injury (Kahraman et al., 2003), ultraviolet
light-induced oxidative stress (Inal and Kahraman, 2000), spon-
taneous hypertension (Duarte et al., 2001), secondary biliary
cirrhosis (Peres et al., 2000), lipopolysaccharide (LPS) (Wadsworth
and Koop, 2001) and carcinogenesis (Yang et al., 2000).
N-acetylcysteine (NAC), used as a standard treatment in the
present study to compare and evaluate the hepatoprotective
effect of quercetin, is a sulfhydryl-containing compound and
capable of rapidly restoring depleted intracellular reduced glu-
tathione (GSH) content (Glantzounis et al., 2004). It has
antioxidant property by acting as a powerful scavenger of free
radicals (Aruoma et al., 1989) and anti-inflammatory proper-
ties (Zafarullah et al., 2003). Also, it is extensively used as a
specific antidote for paracetamol overdose (Dodd et al., 2008).
Moreover, it protects against oxidative stress and ischemic
injury, that’s why it is used for the treatment of several ill-
nesses such as schizophrenia, bipolar disorder (Dodd et al.,
2008), heart disease, cancer (Yousef et al., 2010) and as a mu-
colytic agent for the treatment of bronchopulmonary disease
(Dodd et al., 2008). In addition, it is used as a hepatoprotective
agent in liver transplantation (Thies et al., 1998). Therefore,
the present study aimed to assess the potential protective
effects of quercetin compared to N-acetylcysteine in an ex-
perimental model of I/R-induced liver injury in rats and to
evaluate iNOS, eNOS and NOSTRIN expressions as a possible
mechanism of its hepatoprotective effect.
2. Materials and methods
2.1. Chemicals
Quercetin (QR), N-acetylcysteine (NAC), Thiobarbituric acid,
N-(1-Naphthyl) ethylenediaminedihydrochloride (NEDD), Sul-
fanilamide and Ellman’s reagent (5-5′- dithiobis-(2-nitrobenzoic
acid)) (DTNB), 4,6-diamidino-2-phenylindole (DAPI),
O-dianisidine were purchased from Sigma-Aldrich, USA.
Hexadecyltrimethylammonium bromide (HTAB) was pur-
chased from MP Biomedicals, Inc., USA. Vanadium trichloride
(VCl3) was purchased from Acros, Belgium. Aspartate amino-
transferase (AST) reagent kit and Alanine aminotransferase
(ALT) reagent kit were purchased from Spinreact, Spain. Mouse
polyclonal anti-inducible nitric oxide synthase (anti-iNOS) and
Mouse polyclonal anti-endothelial nitric oxide synthase (eNOS)
were purchased from BD-Bioscience, USA. Rabbit polyclonal
anti-eNOS trafficking inducer (anti-NOSTRIN) was purchased
from Proteintech, USA. Rabbit anti-mouse Alexafluor 488 sec-
ondary antibody was purchased from Invitrogen, USA. Goat anti-
rabbit Cy3 secondary antibody was purchased from Jackson
ImmunoResearch, USA. Other chemicals were selected to be
with the highest analytical grades.
2.2. Animals and experimental protocol
Forty male adultWister albino rats weighing 300–350 gm were
used.This study has been approved by the Research Ethics Com-
mittee of the Faculty of Pharmacy, Beni-Suef University, Egypt
in accordance with the guidelines of the National Institutes
of Health (NIH). Rats were caged at a controlled temperature
of 25 °C under 12 h/12 h light/dark cycle, allowed free access
to food and tap water ad libitum and left for two weeks in
animal house conditions for acclimation. After that, animals
were randomly assigned to four groups each consisting of 10
rats. The first group served as sham-operated control (re-
ceived 0.9% saline and 1% tween80 orally), and underwent
operation similar to the other groups without actual clamp-
ing of the vessels. Group 2 was subjected to ischemia/
reperfusion injury (I/R) (30 minutes ischemia followed by 30
minutes reperfusion) (Su et al., 2003). Groups 3 and 4 were pre-
treated with N-acetylcysteine (NAC) (300mg/kg freshly dissolved
in 0.9% saline) (Hemalatha et al., 2013) and quercetin (QR)
(20 mg/kg suspended in 0.9% saline and 1% tween80) (Yousef
et al., 2010), respectively. Rats were daily administered their
respective doses per oral (p.o) for 10 days before subjection to
I/R.
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2.3. Induction of ischemia/reperfusion in liver
The abdomen was opened through a midline incision under
intraperitoneal ketamine (50 mg/kg) and xylazine HCl (10 mg/
kg) anesthesia (Ara et al., 2005). Dissection of all attached
ligaments connecting the liver, diaphragm and neighboring
organs and liver hilum was exposed to reveal the common
hepatic artery and portal vein. Hepatic ischemia was induced
by occlusion of hepatic pedicle (hepatic artery, portal vein, bile
duct) which supplies the left and medial lobes (70% of the total
liver mass) for 30 minutes with a vascular clamp. Occlusion
was evidenced by immediate liver color change into a paler
shade. The vascular clamp was released and the liver was
reperfused for 30 minutes. 0.5 ml 0.9% saline was given intra-
peritoneally during the period of ischemia (Karabulut et al., 2006)
and the open abdomen was covered by plastic wrap to avoid
dehydration.The body temperature was recorded by rectal ther-
mometer and maintained at 37 ± 0.5 °C by placing the animals
under heating lamp. At the end of reperfusion, blood samples
were collected from the retro-orbital plexus for the determi-
nation of serum aminotransferase, then the animals were
sacrificed and liver was excised and cut into smaller pieces.
Then, it was fixed in Davidson-Solution for immunofluores-
cence assay and in 10% formalin saline for histopathological
evaluation or stored at −80 °C until used for preparation of 25%
liver homogenate for various biochemical determinations.
2.4. Determination of serum aspartate
aminotransferase (AST)
Serum AST was assayed according to the method described
bymanufacturer’s instructions using test reagent kits (Spinreact,
Spain). The absorbance was spectrophotometrically mea-
sured at 340 nm and its activity was expressed in U/L.
2.5. Determination of alanine aminotransferase (ALT)
Serum ALT was measured by the method described by manu-
facturer’s instructions using test reagent kits (Spinreact, Spain).
The absorbance was spectrophotometrically measured at
340 nm and its activity was expressed in U/L.
2.6. Determination of malondialdehyde (MDA) level
Malondialdehyde, as lipid peroxides end product, was mea-
sured according to the method described by Uchiyama and
Mihara (1978). The standard curve was constructed by using
1,1,3,3-tetramethoxypropane. The difference in absorbance,
spectrophotometrically measured at 535 and 520 nm,was used
to calculate the MDA level in each sample and its level was
expressed in nmol/g tissue.
2.7. Determination of reduced glutathione (GSH) content
Reduced glutathione content was assayed by the method of
Beutler et al. (1963).The resulting yellow color absorbance was
spectrophotometrically measured within 5 min at 412 nm and
its content was expressed in mg/g tissue.
2.8. Determination of myeloperoxidase (MPO) activity
Myeloperoxidase activity was assayed using the method of
Krawisz et al. (1984). The absorbance was spectrophoto-
metrically measured at 460 nm using UV-Double Beam spec-
trophotometer. MPO activity was calculated according to the
following equation: MPO activity (U/g tissue) = ΔA/min × D.F/
extinction coefficient; where dilution factor = reciprocal
of the relative sample volume in the reaction mixture ×
dilution factor of the homogenate × 1000. Extinction
coefficient = 1.13 × 104 Cm−1 M−1.
2.9. Determination of nitric oxide (NO) content
The content of NO was measured according to the
method of Miranda et al. (2001). In the presence of molecular
oxygen, NO was relatively unstable and rapidly oxidized
to nitrite and nitrate totally designated as (NOx). The
absorbance was spectrophotometrically measured at
540 nm. NO content was calculated according to the stan-
dard curve using NaNO3 and its production was expressed in
μM/g tissue.
2.10. Examination of histopathological sections
Liver samples were sliced and immediately fixed in 10% for-
malin saline for 72 h. Then, they were processed according to
Bancroft and Gamble (2008) and stained with conventional he-
matoxylin and eosin (H&E) stain. Finally, microscopical
examination and photomicrography of various groups was
performed.
2.11. Immunofluorescence assay of iNOS, eNOS and
NOSTRIN expressions
Paraffin tissue sections were deparaffinized by heating at 56 °C
for 20 min, then cleaned using xylene 100% two times, 15 min
each and rehydrated using gradient concentrations of ethanol
100% for 5 min two times, 90%, 70%, 50% and 30%, 5 min each.
After rehydration, tissue was washed with distilled water for
5 min and incubated in Dako solution (citrate buffer, pH 6) in
microwave at 500 watt for 20 min for antigen retrieval. After
cooling of the solution, slides were washed three times by
phosphate buffered saline (PBS), pH 7.4 containing 0.5% tween
20. Fixation was done using absolute methanol for 30 min.
After washing, sections were blocked with PBS containing 10%
horse serum and 1% bovine serum albumin at room temp.
for 1 h to block the non-specific binding of antibodies. The
primary antibodies (Mouse polyclonal iNOS or eNOS or Rabbit
polyclonal NOSTRIN antibodies) were incubated with tissue
sections overnight in 4 °C in the concentration of 1:50. Bound
antibodies were detected by rabbit anti-mouse Alexafluor 488
(Green) or goat anti-rabbit Cy3 (Red) (Molecular Probes) sec-
ondary antibodies for 30 min, respectively. Nuclei were
stained with DAPI and washed by PBST for 30 min. Slides were
mounted with Fluoromount, covered by covering slips and
allowed to be evaluated by fluorescence microscopy (Leica
DM5000 B).
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2.12. Statistical analysis
Statistical analysis of the results was performed using the sta-
tistical package for social sciences (SPSS) software (version 22.0).
Data were expressed as means ± standard error (S.E.). All pa-
rameters were analyzed using one-way analysis of variance
(ANOVA) and the Tukey test for post hoc multiple compari-
son. Results were graphically represented by bar charts. A P
value less than 0.05 was considered as statistically signifi-
cant difference.
3. Results
3.1. Effect of QR in I/R subjected rats on serum AST and
ALT activities
Serum liver toxicity markers, AST and ALT, were depicted in
Fig. 1A and B, respectively. I/R group significantly increased
serum AST and ALT activities to about 914.16 ± 46.88% and
846.46 ± 91.92%, respectively, compared to the corresponding
sham-operated control group. QR-pretreatment exhibited a sig-
nificant decrease in liver enzymes to about 41.77 ± 3.09% and
55.91 ± 2.45%, respectively, while NAC-pretreatment showed
lowered AST and ALT activities to about 66.04 ± 2.42% and
67.10 ± 5.22%, respectively, compared to I/R group.
3.2. Effect of QR in I/R subjected rats on hepatic MDA
level and GSH content
Hepatic MDA level significantly increased in I/R group to about
240.10 ± 24.51% while the GSH content significantly depleted
to about 20.24 ± 0.96% compared to the corresponding sham-
operated rats. QR-pretreated rats significantly decreased lipid
peroxidation to about 71.72 ± 3.17% while significantly in-
creased GSH level to reach 411.76 ± 11.76% compared to I/R
group. NAC-pretreatment significantly reduced MDA level to
about 79.70 ± 9.82% while significantly restored the depleted
GSH content to reach 476.47 ± 23.53% compared to I/R group
(Fig. 2A and B, respectively).
3.3. Effect of QR in I/R subjected rats on hepatic MPO
activity and NO production
The hepatic MPO activity and NO production were
represented in Fig. 2C and D, respectively. I/R subjected
rats significantly increased MPO activity and NO production
to about 617.65 ± 70.59% and 254.79 ± 6.99%, respectively,
compared to sham-operated animals. QR-pretreated
I/R rats significantly decreased MPO activity and NO produc-
tion to about 36.19 ± 3.81% and 80.19 ± 4.90%, respectively,
compared to IR group. Similarly, NAC-pretreated I/R animals
significantly decreasedMPO activity and NO production to about
43.81 ± 5.71% and 78.98 ± 4.03%, respectively, compared to I/R
group.
3.4. Histopathological examination of liver sections
Liver sections obtained from sham-operated control group
showed normal hepatic architecture with cords of normal he-
patocytes radiating from the central vein (CV) and separated
by blood sinusoids lined with endothelium and Kupffer cells
(KC) (arrow) (Fig. 3A) while I/R subjected rats revealed that many
Fig. 1 – Effect of QR in I/R subjected rats on serum AST and ALT activities. (A) Serum AST activity of sham-operated control
and I/R with or without NAC or QR-pretreatment. (B) Serum ALT activity of sham-operated control, I/R, and of NAC and QR-
pretreatment. All data were expressed as means ± standard error (S.E.). *Significantly different from sham-operated group at
P < 0.05; @Significantly different from I/R group at P < 0.05. Means with the same superscript symbol are not significantly
different at P < 0.05.
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hepatocytes showed cytoplasmic degeneration and inflam-
matory cells infiltration (head arrow). In addition, massively
dilated congested central vein and dilated congested blood si-
nusoids lined with activated Kupffer cells were noticed (Fig. 3B-1
and 3B-2). QR or NAC-pretreated group maintained normal his-
topathological picture. Meanwhile, the CV is still dilated and
congested (Fig. 3C and 3D).
3.5. Effect of QR in I/R subjected rats on iNOS, eNOS and
NOSTRIN protein expressions
Sham-operated rats showed negative iNOS and NOSTRIN
protein expressions while I/R subjected animals revealed in-
crease in iNOS and NOSTRIN expressions in the pericentral
hepatocytes compared to sham-operated group while QR or
NAC-pretreatment showed decrease in iNOS and NOSTRIN
expressions interstitially closed to the central area compared
to the I/R group (Figs. 4A and 5A). Semi-quantitative analysis
of the immunofluorescence staining expressed as fluores-
cence intensity stated that I/R group significantly increased iNOS
and NOSTRIN expressions in liver tissues to about 153.10 ± 9.68%
and 197.14 ± 6.50%, respectively, compared to the sham-
operated group. On the other hand, QR or NAC-pretreatment
significantly decreased iNOS and NOSTRIN expressions to about
71.29 ± 2.42% and 72.56 ± 4.77% or 72.61 ± 3.13% and
55.07 ± 3.18%, respectively, compared to I/R processed group
(Figs. 4B and 5B).
Sham-operated rats revealed sinusoidal eNOS protein ex-
pression. Conversely, liver sections obtained from I/R exposed
rats showed decrease in eNOS expression compared to sham-
operated group, whereas QR and NAC-pretreatment showed
increase in eNOS expression in the sinusoidal areas as well
Fig. 2 – Effect of QR in I/R subjected rats on oxidative stress parameters and NO content. (A) Hepatic MDA level of sham-
operated control, I/R, I/R with or without NAC or QR-pretreatment. (B) Hepatic GSH content of sham-operated control, I/R,
and of NAC and QR-pretreatment. (C) Hepatic MPO activity of sham-operated control, I/R, I/R with or without NAC or QR-
pretreatment. (D) Hepatic NO content of sham-operated control, I/R, and of NAC and QR-pretreatment. All data were
expressed as means ± standard error (S.E.). *Significantly different from sham-operated group at P < 0.05; @Significantly
different from I/R group at P < 0.05. Means with the same superscript symbol are not significantly different at P < 0.05.
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as in periportal and pericentral hepatocytes compared to I/R
group (Fig. 6A). Fluorescence intensity of eNOS stated that I/R
operated group significantly decreased eNOS protein expres-
sion in liver tissues to about 51.75 ± 2.29% compared to sham-
operated control. On the other hand, pretreatment with QR
or NAC significantly increased eNOS expression to about
166.54 ± 7.82% and 153.27 ± 7.48%, respectively, compared to
I/R group (Fig. 6B).
4. Discussion
In a variety of clinical conditions such as liver surgery, par-
ticularly in transplantation and hepatic trauma of diverse origins
and hepatic failure after shock, ischemia/reperfusion is one of
the major obstacles faced. Oxidative and nitrosative stress-
induced cell damage and inflammatory reactions play an
essential role in the pathogenesis of I/R injury. In the present
study, hepatic I/R showed significant rises in the serum AST
and ALT activities. In addition, it significantly increased hepatic
MPO activity, MDA level and NO production. On the other hand,
it significantly depleted GSH content along with marked his-
topathological changes in liver tissues. Moreover, it strongly
increased hepatic iNOS and NOSTRIN expressions in addi-
tion to decreased eNOS expression.Analysis of our data revealed
the fact that pretreatment with QR prior to ischemia seems
to be required in order to obtain the hepatoprotection against
I/R, as showed by a significant decrease in serum levels of AST
and ALT compared to IR group. These results are in a good
agreement with a recent study which demonstrated that QR
treatment significantly decreased ALT and AST activities in rats
subjected to liver injury induced by ethanol (Chen, 2010). Con-
cerning the lipid peroxidation (assessed by the hepatic MDA
level) and the reduced GSH content, QR-pretreatment signifi-
cantly reduced the MDA level while markedly restored GSH
depletion compared to animals subjected to I/R, supporting its
antioxidant effects as reported by other studies (Tokyol et al.,
2006; Yousef et al., 2010). Interestingly, pretreatment with QR
significantly decreased hepatic MPO activity, suggesting that
the hepatoprotective effect of this compound is related as well
to its anti-inflammatory properties. These findings were con-
firmed by marked improvement in the liver cell structure and
decreased inflammatory cells infiltration as shown by
Fig. 3 – Histopathological examination of liver sections. (A) Sham-operated control group: Showed normal hepatic
architecture. (B-1) I/R group: Showed massively dilated and congested central vein (CV). Hepatocytes are separated by
dilated congested blood sinusoids with aggregated Kupffer cells (arrow). (B-2) IR group: Showed dilated and congested
central vein. Many hepatocytes showed extensive inflammatory reaction (head arrow). (C) NAC-pretreated group: Showed
slightly dilated and congested central vein. Hepatocytes are separated by slightly dilated congested blood sinusoids with
Kupffer cells (arrow). (D) QR-pretreated group: Showed dilated and congested central vein. Normal hepatocytes are
separated by slightly dilated congested blood sinusoids with Kupffer cells (arrow). (H&E 400×).
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histopathological examination. Similar results were obtained
by previous studies of Kahraman et al. (2003) who stated that
QR significantly decreased MPO activity in a model of I/R-
induced renal injury and Tokyol et al. (2006) who stated that
histopathological liver damage scores significantly decreased
in QR-pretreated I/R animals compared to I/R alone. Further-
more, in the current study, QR significantly suppressed iNOS
expression and decreased NO production and subsequently its
potent oxidative byproduct, peroxynitrite. Therefore, QR in-
hibited nitrosative stress injury. Similar results have been
Fig. 4 – Effect of QR in I/R subjected rats on iNOS protein expression. (A) iNOS protein expression in the liver sections. It was
detected by binding with mouse polyclonal iNOS antibody, then this bound antibody was detected by rabbit anti-mouse
Alexafluor 488 (green) as a secondary antibody and the nuclei were counterstained using DAPI (blue). Figures were captured
using immunofluorescence microscope (Leica DM5000B) and analyzed using Image J software (NIH). Scale bar = 100 μM. (B)
Semi-quantitative analysis of the immunofluorescence staining expressed as fluorescence intensity of iNOS protein
expression of sham-operated control and I/R with or without NAC or QR-pretreatment. All data were expressed as
means ± standard error (S.E.). *Significantly different from sham-operated group at P < 0.05; @Significantly different from IR
group at P < 0.05.
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reported by Martínez-Flórez et al. (2005) who demonstrated that
QR inhibited NO production through the inhibition of iNOS ex-
pression in interleukin (IL)-1β-stimulated hepatocytes. Also, QR
significantly increased eNOS along with decreased NOSTRIN
expression. Our finding of increased eNOS protein expres-
sion is consistent with Vicente-Sánchez et al. (2008) who
reported that QR treatment significantly increased hepatic eNOS
expression in a model of cadmium-induced hepatotoxicity.The
involvement of NOSTRIN, eNOS and NO in IR with or without
QR-pretreatment so far remain least explored. The increased
protein expression of NOSTRIN may partly contribute to I/R
injury.This finding is in accordance with Mookerjee et al. (2007)
Fig. 5 – Effect of QR in I/R subjected rats on NOSTRIN protein expression. (A) NOSTRIN protein expression in the liver
sections. NOSTRIN protein expression was detected in the liver of different groups using rabbit polyclonal iNOS antibody,
detected by goat anti-rabbit cy3 (red) and the nuclei were counterstained using DAPI (blue). Scale bar = 50 μM. (B)
Fluorescence intensity of NOSTRIN protein expression of sham-operated control and I/R with or without NAC or QR-
pretreatment. All data were expressed as means ± standard error (S.E.). *Significantly different from sham-operated group at
P < 0.05; @Significantly different from IR group at P < 0.05.
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who demonstrated that the increased gene and protein ex-
pression of NOSTRINmay partly contribute to the reduced eNOS
activity and increased intrahepatic resistance in patients with
alcoholic hepatitis. On the other hand, QRmight protect against
I/R injury by decreasing the increased protein expression of
NOSTRIN.
5. Conclusions
Quercetin exhibited a more pronounced hepatoprotection as
it successfully restored liver function and architecture. Also,
it inhibited oxidative and nitrosative injury induced by I/R
Fig. 6 – Effect of QR in I/R subjected rats on eNOS protein expression. (A) eNOS protein expression in the liver sections.
Sham-operated rats’ livers showing sinusoidal eNOS expression. Ischemia/reperfusion liver tissues presenting reduced
eNOS expression in the sinusoidal area of the liver compared to sham operated rats. NAC and QR-pretreatment showed
restoration of eNOS expression interstitially and in hepatocytes compared to IR operated animals. Scale bar = 100 μM. (B)
Fluorescence intensity of eNOS protein expression of sham-operated control and I/R with or without NAC or QR-
pretreatment. All data were expressed as means ± standard error (S.E.). *Significantly different from sham-operated group at
P < 0.05; @Significantly different from IR group at P < 0.05.
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compared with N-acetylcysteine. Still, further investigations
should be done to investigate its potential uses in clinical trial.
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